Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer Subjects

This study is ongoing, but not recruiting participants.

Sponsor:

Information provided by (Responsible Party):

OBI Pharma, Inc

ClinicalTrials.gov Identifier:

NCT01516307

First received: January 19, 2012

Last updated: September 9, 2016

Last verified: September 2016

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	February 2017
Estimated Primary Completion Date:	December 2016 (Final data collection date for primary outcome measure)